VOYAGER
LIVE

Serial Number

97044610

Owner

Voyager Therapeutics, Inc.

Attorney

Keith Toms, Esq.

Filing Date

Sep 24, 2021

Add to watchlist:

No watchlists yet
View on USPTO

VOYAGER Trademark

Serial Number: 97044610

VOYAGER is a trademark filed by Voyager Therapeutics, Inc. on September 24, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Voyager Therapeutics, Inc. (18 trademarks)

75 Hayden Avenue
Lexington, MA 02421

Entity Type: 03

Trademark Details

Filing Date

September 24, 2021

Registration Date

Not Registered

Published for Opposition

July 15, 2025

Goods & Services

Medical services provided for clinical trials; Providing patient care for clinical trials; Providing medical and scientific research information in the field of clinical trials and gene therapy; Providing a website featuring medical information and medical research; medical treatment of neurological diseases via gene replacement, gene knockdown, or vectorized antibodies, namely, Parkinson's disease, Huntington's disease, Friedreich's ataxia, amyotrophic lateral sclerosis (ALS), Alzheimer's disease, tauopathies, synucleinopathies, and neurodegenerative disease*

Pharmaceutical research and development in the field of gene therapy; Pharmaceutical research and development for the treatment of neurological diseases and disorders; scientific research in the field of gene therapy; pharmaceutical research services; research and development of pharmaceutical preparations for gene therapy; research and development of pharmaceutical preparations for neurological diseases; biotechnology research services; research and development of platform technologies for genetic delivery of therapies and pharmaceuticals; research and development services in the field of platforms technologies for genetic delivery of therapies and pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; research and development regarding the use of RNA-derived functional screening platforms to discover, research and develop novel capsids for genetic deliver of therapies and pharmaceuticals; research and development regarding the identification and targeting of specific cells and tissues for gene therapy delivery

Biological preparations for gene therapy; adeno-associated virus (AAV) gene therapy preparations and pharmaceuticals; Biological preparations for treatment of neurological diseases and disorders; gene therapy preparations for treatment of disease, namely, neurological diseases; medical preparations and pharmaceuticals for treatment of neurological diseases via gene replacement, gene knockdown, or vectorized antibodies; gene therapy preparations for neurological diseases; nucleic acids encoding polypeptides for gene therapy; Drug delivery agents comprising compounds that facilitate delivery of a wide range of pharmaceuticals and biotherapeutics; Drug delivery agents comprising capsids that facilitate delivery of a wide range of pharmaceuticals and biotherapeutics

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 10, 2026 EXRA
SOU EXTENSION 1 GRANTED
Mar 9, 2026 EX1G
SOU EXTENSION 1 FILED
Mar 9, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 9, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 9, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 15, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jul 15, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 9, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 9, 2025 CNSA
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
May 30, 2025 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 20, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 26, 2024 RCSC
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 22, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 22, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 22, 2024 COAR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 5, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 19, 2023 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 14, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 14, 2022 GNSL
SUSPENSION LETTER WRITTEN
Nov 14, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 11, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 10, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 10, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 10, 2022 GNRN
NON-FINAL ACTION E-MAILED
May 10, 2022 GNRT
NON-FINAL ACTION WRITTEN
May 10, 2022 CNRT
ASSIGNED TO EXAMINER
May 7, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 27, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 26, 2021 NWOS
NEW APPLICATION ENTERED
Sep 28, 2021 NWAP